Page last updated: 2024-11-06

ruberythric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Ruberythric acid is a natural anthraquinone glycoside found in madder root (Rubia tinctorum). It is a precursor to alizarin, a red dye that has been used for centuries. Ruberythric acid is synthesized in the plant by a complex pathway that involves several enzymes. It is thought to play a role in plant defense mechanisms and may also have antioxidant properties. Ruberythric acid has been studied for its potential medicinal uses, including its anti-inflammatory and anticancer effects. It has also been investigated for its use in the production of biofuels. Ruberythric acid is an important compound in the study of plant metabolism and biosynthesis, as well as in the development of new drugs and materials.'

ruberythric acid: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID92101
SCHEMBL ID2135802
MeSH IDM0177231

Synonyms (25)

Synonym
einecs 205-808-9
brn 0071586
ccris 4531
1-hydroxy-2-((6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy)anthraquinone
alizarin primeveroside
glucopyranoside, 1-hydroxy-2-anthraquinonyl 6-o-beta-d-xylopyranosyl-, beta-d-
rubierythric acid
rubianic acid
ruberythric acid
beta-d-1-hydroxy-2-anthraquinonyl 6-o-beta-d-xylopyranosylglucopyranoside
1-hydroxy-2-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
SCHEMBL2135802
unii-4360a2y7jd
152-84-1
4360a2y7jd ,
rubian
ruberythrinic acid
1-hydroxy-2-anthraquinonyl 6-o-.beta.-d-xylopyranosyl-.beta.-d-glucopyranoside
ruberythric acid [mi]
1-hydroxy-2-[(6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy]anthraquinone
ruberythric acid (alizarin-2-beta-d-primeveroside)
Q733425
1-hydroxy-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione
DTXSID701026553
AKOS040735719
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's4 (36.36)18.2507
2000's5 (45.45)29.6817
2010's1 (9.09)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.88 (24.57)
Research Supply Index2.56 (2.92)
Research Growth Index4.81 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other12 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]